Report cover image

Anti-Neoplastic Agents Global Market Opportunities And Strategies To 2034

Publisher The Business Research Company
Published Jul 09, 2025
Length 344 Pages
SKU # BRC20178137

Description

Anti-Neoplastic Agents Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global anti-neoplastic agents market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for anti-neoplastic agents? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The anti-neoplastic agents market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider anti-neoplastic agents market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by disease type and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the ma-rket values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by disease type and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for anti-neoplastic agents providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:

1) By Type: Alkylating Agents; Antimetabolites; Hormones And Antagonists; Miscellaneous

2) By Disease Type: Gastrointestinal Cancer; Prostate Cancer; Lung Cancer; Breast Cancer; Other Disease Types

3) By End User: Hospitals; Clinics; Cancer Rehabilitation Centers; Ambulatory Surgical Centers; Other End Users

Companies Mentioned: Merck & Co. Inc.; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Johnson & Johnson; AstraZeneca plc

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; anti-neoplastic agents indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

344 Pages
1 Executive Summary
1.1 Anti-Neoplastic Agents – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Anti-Neoplastic Agents Market Definition And Segmentations
6.4 Market Segmentation By Type
6.4.1 Alkylating Agents
6.4.2 Antimetabolites
6.4.3 Hormones And Antagonists
6.4.4 Miscellaneous
6.5 Market Segmentation By Disease Type
6.5.1 Gastrointestinal Cancer
6.5.2 Prostate Cancer
6.5.3 Lung Cancer
6.5.4 Breast Cancer
6.5.5 Other Disease Types
6.6 Market Segmentation By End User
6.6.1 Hospitals
6.6.2 Clinics
6.6.3 Cancer Rehabilitation Centers
6.6.4 Ambulatory Surgical Centers
6.6.5 Other End Users
7 Major Market Trends
7.1 Advancing Cancer Treatment Through Precision Medicine
7.2 Enhancing Treatment Precision With Targeted Therapies
7.3 Minimizing Toxicity Through Precision Oncology Approaches
7.4 Enhancing Cancer Outcomes Through Signal Pathway Inhibition
8 Anti-Neoplastic Agents Growth Analysis And Strategic Analysis Framework
8.1 Global Anti-Neoplastic Agents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
8.1.1 Political
8.1.2 Economic
8.1.3 Social
8.1.4 Technological
8.1.5 Environmental
8.1.6 Legal
8.2 Analysis Of End User
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Cancer Rehabilitation Centers
8.2.4 Ambulatory Surgical Centers
8.3 Anti-Neoplastic Agents Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)
8.4.1 Market Drivers 2019 – 2024
8.4.2 Market Restraints 2019– 2024
8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
8.6.1 Quantitative Growth Contributors
8.6.2 Drivers
8.6.3 Restraints
8.7 Anti-Neoplastic Agents Total Addressable Market (TAM)
9 Anti-Neoplastic Agents Market Segmentation
9.1 Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.2 Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.3 Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.4 Anti-Neoplastic Agents Market, Sub-Segmentation By Alkylating Agents, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.5 Anti-Neoplastic Agents Market, Sub-Segmentation Of Antimetabolites, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.6 Anti-Neoplastic Agents Market, Sub-Segmentation By Hormones And Antagonists, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.7 Anti-Neoplastic Agents Market, Sub-Segmentation By Miscellaneous, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 Anti-Neoplastic Agents Market, Regional and Country Analysis
10.1 Anti-Neoplastic Agents Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.2 Anti-Neoplastic Agents Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.2 Market Overview
11.2.1 Region Information
11.2.2 Market Information
11.2.3 Background Information
11.2.4 Government Initiatives
11.2.5 Regulations
11.2.6 Regulatory Bodies
11.2.7 Major Associations
11.2.8 Taxes Levied
11.2.9 Corporate Tax Structure
11.2.10 Investments
11.2.11 Major Companies
11.3 Asia-Pacific Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Anti-Neoplastic Agents Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
11.9.1 Country Information
11.9.2 Market Information
11.9.3 Background Information
11.9.4 Government Initiatives
11.9.5 Regulations
11.9.6 Regulatory Bodies
11.9.7 Major Associations
11.9.8 Taxes Levied
11.9.9 Corporate Tax Structure
11.9.10 Investments
11.9.11 Major Companies
11.10 China Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.11 China Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.12 China Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.15 India Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.16 India Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
11.19.1 Country Information
11.19.2 Market Information
11.19.3 Background Information
11.19.4 Government Initiatives
11.19.5 Regulations
11.19.6 Regulatory Bodies
11.19.7 Major Associations
11.19.8 Taxes Levied
11.19.9 Corporate Tax Structure
11.19.10 Investments
11.19.11 Major Companies
11.20 Japan Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
11.33.1 Country Information
11.33.2 Market Information
11.33.3 Background Information
11.33.4 Government Initiatives
11.33.5 Regulations
11.33.6 Regulatory Bodies
11.33.7 Major Associations
11.33.8 Taxes Levied
11.33.9 Corporate Tax Structure
11.33.10 Investments
11.33.11 Major Companies
11.34 South Korea Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate tax structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Western Europe Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Anti-Neoplastic Agents Market: Country Analysis
12.7 UK Market
12.8 UK Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.17 France Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.18 France Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Investments
13.2.11 Major companies
13.3 Eastern Europe Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Anti-Neoplastic Agents Market: Country Analysis
13.7 Russia Market
13.8 Russia Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 North America Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Anti-Neoplastic Agents Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
14.9.1 Country Information
14.9.2 Market Information
14.9.3 Background Information
14.9.4 Government Initiatives
14.9.5 Regulations
14.9.6 Regulatory Bodies
14.9.7 Major Associations
14.9.8 Taxes Levied
14.9.9 Corporate Tax Structure
14.9.10 Major Companies
14.10 USA Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
14.15.1 Country Information
14.15.2 Market Information
14.15.3 Background Information
14.15.4 Government Initiatives
14.15.5 Regulations
14.15.6 Regulatory Bodies
14.15.7 Major Associations
14.15.8 Taxes Levied
14.15.9 Corporate Tax Structure
14.15.10 Investments
14.15.11 Major Companies
14.16 Canada Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 South America Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Anti-Neoplastic Agents Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 Middle East Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Investments
17.2.11 Major Companies
17.3 Africa Anti-Neoplastic Agents Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Anti-Neoplastic Agents Market, Segmentation By Disease Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Anti-Neoplastic Agents Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles
18.1 Company Profiles
18.2 Merck & Co., Inc
18.2.1 Company Overview
18.2.2 Products And Services
18.2.3 Business Strategy
18.2.4 Financial Overview
18.3 Bristol Myers Squibb Company
18.3.1 Company Overview
18.3.2 Products And Services
18.3.3 Business Strategy
18.3.4 Financial Overview
18.4 F. Hoffman-La Roche Ltd
18.4.1 Company Overview
18.4.2 Products And Services
18.4.3 Business Strategy
18.4.4 Financial Overview
18.5 Johnson & Johnson
18.5.1 Company Overview
18.5.2 Products And Services
18.5.3 Business Strategy
18.5.4 Financial Overview
18.6 AstraZeneca plc
18.6.1 Company Overview
18.6.2 Products And Services
18.6.3 Business Strategy
18.6.4 Financial Overview
19 Other Major And Innovative Companies
19.1 Novartis AG
19.1.1 Company Overview
19.1.2 Products And Services
19.2 Pfizer Inc
19.2.1 Company Overview
19.2.2 Products And Services
19.3 Eli Lilly and Company
19.3.1 Company Overview
19.3.2 Products And Services
19.4 AbbVie
19.4.1 Company Overview
19.4.2 Products And Services
19.5 Boehringer Ingelheim GmbH
19.5.1 Company Overview
19.5.2 Products And Services
19.6 Takeda Pharmaceutical Company Limited
19.6.1 Company Overview
19.6.2 Products And Services
19.7 Sanofi S.A.
19.7.1 Company Overview
19.7.2 Products And Services
19.8 Amgen Inc
19.8.1 Company Overview
19.8.2 Products And Services
19.9 Bayer AG
19.9.1 Company Overview
19.9.2 Products And Services
19.10 Hikma Pharmaceuticals plc
19.10.1 Company Overview
19.10.2 Products And Services
19.11 Fresenius SE & Co. KGaA
19.11.1 Company Overview
19.11.2 Products And Services
19.12 Teva pharmaceutical Industries Ltd
19.12.1 Company Overview
19.12.2 Products And Services
19.13 Ipsen SA
19.13.1 Company Overview
19.13.2 Products And Services
19.14 Incyte Corp
19.14.1 Company Overview
19.14.2 Products And Services
19.15 Aspen Pharmacare Holdings Limited
19.15.1 Company Overview
19.15.2 Products And Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions
22.1 Novartis Acquired Mariana Oncology
22.2 Johnson & Johnson (J&J) Acquired Ambrx Biopharma
22.3 Ipsen SA Acquired Epizyme Inc
23 Recent Developments In Anti-neoplastic Agents
23.1 Therapeutic Advancement For Renal And Breast Cancer Care
23.2 Next-Generation Therapy Targets Malignant B Cells Effectively
23.3 Revolutionary Immuno-Oncology Therapy For Nasopharyngeal Carcinoma
23.4 Novel Liposomal Doxorubicin Formulation Targets Multiple Cancer Types
24 Opportunities And Strategies
24.1 Anti-Neoplastic Agents Market In 2029 – Countries Offering Most New Opportunities
24.2 Anti-Neoplastic Agents Market In 2029 – Segments Offering Most New Opportunities
24.3 Anti-Neoplastic Agents Market In 2029 – Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Anti-Neoplastic Agents Market, Conclusions And Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us